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The COVID-19 outbreak caused by the novel coronavirus, SARS-CoV-2, 
typically presents with symptoms including fever, cough, headache, 
myalgia, asthenia, anosmia, diarrhea, and sometimes pneumonia, 
which can be fatal.  Recently, new dermatologic findings have been 
described in association with the disease that can potentially be a 
distinguishing feature of infection. One such feature resembles 
chilblains and this case report represents a presentation of this 
feature with a 48-year-old female with violaceous lesions with 
surrounding pink erythema on her toes who tested negative for 
COVID-19.
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Introduction
The COVID-19 outbreak caused by the novel coronavirus, 
SARS-CoV-2, typically presents with symptoms including 
fever, cough, headache, myalgia, asthenia, anosmia, diarrhea, 
and sometimes pneumonia, which can be fatal. Recently, new 
dermatologic findings have been described in association with 
the disease that can potentially be a distinguishing feature 
of infection. One such feature resembles chilblains1. Chilblains- 
like lesions, described in multiple case reports from around 
the globe, have demonstrated either an erythematous- 
edematous or blistering skin lesion that mostly affects the toes 
and soles. Over the course of one to two weeks, lesions become 
more purpuric and flatten, finally resolving spontaneously 
without any treatment. The majority of patients with 
chilblains-like lesions are generally in good health, without sig-
nificant coronavirus symptoms, may have a recent history of 
mild upper respiratory symptoms, but no prior history of similar 
cutaneous lesions2. By contrast, non-COVID-19-related 
chilblains are associated with exposure to low temperatures and 
may be associated with autoimmune disorders (chilblain lupus), 
hematologic disorders and rarely viral infections. During 
recent months, chilblains-like lesions has been reported in 
association with COVID-19, although the timing of these 
lesions relative to active infection appears to vary. In a cohort 
of patients reported from Italy, some patients developed skin 
findings only during the initial course of disease, while others 
reported onset at later stages3.
The ill-defined timing of presentation of chilblains-like lesions 
in confirmed COVID-19 positive patients may be associated 
with onset, progression or resolution of the disease. Due to 
potentially unreliable and subjective patient reporting, lack of 
awareness that these lesions may be a symptom of COVID-19 
disease, and limited coronavirus testing availability, the diagno-
sis of COVID-19 and/or chilblains-like lesions may be missed or 
unreported. Based on our experience with the COVID-19 
population in Oregon, we hypothesize that there may be a limited 
and possibly non-overlapping diagnostic window for COVID-19 
infection and chilblains-like lesions. If true, this could result in 
classic chilblains-like lesions features in the absence of a posi-
tive COVID-19 diagnostic test. Here, we present the case of a 
48-year-old healthy woman, who presented with chilblains-like 
lesions on her toes and tested as negative for COVID-19.
Case report
A 48-year-old healthy female patient presented to our hospital 
with chilblains-like lesions on her toes. She had no other 
underlying diseases and denied recent exposure to cold tem-
peratures. She is a healthcare provider with potential exposure 
to SARS-CoV-2. The patient reported upper respiratory symp-
toms four weeks prior to development of lesions, which included 
mild sore throat, non-productive cough, and chest pain. A viral 
test was unavailable at that time. Her highest temperature was 
99.4°F. Concurrent with the onset of cutaneous manifestations, 
she and her husband both experienced intermittent diarrhea over 
a period of 3 days without any recurrent respiratory symptoms or 
fever. Two 9-year old children in the home were asymptomatic. 
The patient began developing small blisters on both her feet, 
starting with a single, isolated lesion on the bottom of one 
toe. Additional lesions developed on the lateral aspects and 
top of 6 toes, primarily at the distal aspect. The cutaneous 
lesions slowly progressed from pink macules and papules to 
violaceous lesions with surrounding pink erythema (Figure 1).
A 3mm punch biopsy was taken on the patient’s third left 
lateral toe in the most prominent area of chilblains-like lesions 
findings approximately 2 weeks after the onset of lesions and 
during early stages of lesion resolution. Pathologic findings 
included parakeratosis, overlying vacuolar alteration of the basal 
layer with dyskeratosis, fibrinoid degeneration and edema of the 
papillary dermis (Figure 2). No thrombi were seen. Superficial 
and deep perivascular lymphocytic infiltrate with extravasated 
red cells were also present with a final pathologic diagno-
sis of chilblains/perniosis, consistent with those seen in 
COVID-associated chilblains-like lesions (“COVID-toes”). 
Immunohistochemical analysis demonstrated the perivascular 
lymphocytic infiltrate to be composed predominantly of 
CD3+ T cells, with very rare CD20+ B cells. The T cells dem-
onstrated an unremarkable CD4:CD8 ratio. Rare CD163+ 
histiocytes were scattered throughout.
An in vivo virtual biopsy with reflectance confocal microscopy 
(RCM; Vivascope 3000, Caliber I.D., Rochester, NY, USA) was 
performed on the same toe that was examined histologically. 
Findings included an irregular epidermis with broadened 
honeycombed pattern and absence of pagetoid cells. In the 
dermal-epidermal junction, enlarged and swollen highly reflec-
tive papillae as well as dendritic cells (activated Langerhans 
cells) and bright dots representing inflammatory infiltrate were 
present. Within two days of the biopsy and virtual biopsy, the 
patient was tested for SARS-COV-2 (PCR) and antibodies, 
neither of which yielded a positive result. The timing of 
the tests or failure of many to mount an antibody-mediated 
response make it difficult to determine whether this is a 
COVID-related case or not, since the specificity of available 
testing is low. No therapeutic intervention was made and 
upon follow-up the patients symptoms resolved.
Of interesting note, the patient reported that at the same time 
she and her husband developed the gastrointestinal symp-
toms, her elderly pet cat also developed an upper respiratory 
infection with a three-day history of lethargy, loss of appetite 
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Figure 1. Initial presentation of patient and her pet cat. (A) Clinical images taken of the patient’s left foot, showing multiple well 
circumscribed violaceous discolorations with surrounding pink erythema on the distal toes. (B) Closeup of the chilblains-like lesions. 
(C) Dermoscopy image of the fourth toe showing multiple red globules. (D) Patient-submitted clinical photos of her indoor pet cat with 
multiple red-purple well-circumscribed slightly raised spots bilaterally that also resolved spontaneously. Additionally, ocular discharge was 
present.
Figure 2. Biopsy imaging. (A) Reflectance confocal microscopy (RCM) image (1mm x 1mm) of the biopsied toe showing an enlarged 
keratinocytes and presence of dendritic cells (activated Langerhans cells in the circle). (B) RCM image (1mm x 1mm) of the epidermis and 
dermal epidermal junction showing bright white dots representing inflammatory cells (↑) and an enlarged, bright and reflective swollen 
dermal papillae (↓). (C) Histopathology H&E image at 10x magnification. (D) Histopathology H&E image at 10x magnification stained for CD8, 
which shows the vast majority of lymphocytes to be T cells with a relatively unremarkable CD4:CD8 ratio, present mostly in a perivascular 
distribution and in the superficial dermis.
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and increased sneezing and coughing, which spontaneously 
resolved. Additionally, the interior distal aspect of the cat’s 
ears developed multiple red-purple, well-circumscribed, slightly 
raised spots bilaterally that resembled the patient’s cutaneous 
findings. These lesions resolved within 3 weeks of onset.
Discussion
Cutaneous lesions associated with coronavirus-induced vasculitis 
has been previously reported in a cat with feline infectious 
peritonitis and concurrent feline immunodeficiency virus 
infection4. In this case, the animal presented with a similar 
two-week history of pyrexia, loss of appetite and weight 
loss, sneezing, bilateral nasal and ocular discharge to our 
patient’s cat. The cat described in this previous case report 
presented with multiple well-circumscribed slightly raised, 
red nodules and positive FCoV4. Recently at the Bronx Zoo 
in New York, eight big cats (5 tigers and 3 lions) have tested 
positive for the COVID-19 virus and are believed to have 
been infected by an asymptomatic zookeeper. The cats started 
showing symptoms including a dry cough, with one tiger 
who did not show any symptoms for coronavirus5. A recent 
publication also suggests that cats may be intermediate hosts 
of the SARS-Cov-26,7.
This is the first report of reflectance confocal microscopy 
findings in chilblains-like lesions and the large number of den-
dritic antigen-presenting cells may be a distinguishing fea-
ture in its presentation. Further studies are needed to determine 
if these RCM findings are exclusive to chilblains-like lesions, 
due to the negative COVID-19 result, or also found in traditional 
chilblains. It is not possible to conclude that our patient had 
COVID-19-associated chilblains-like lesions because she 
did not have a positive viral or antibody test and may be a lim-
itation to our findings. However, she did have a pattern of 
development that is highly suspicious for infection-induced 
chilblains-like lesions, including a history of respiratory and 
gastrointestinal symptoms, aged below 50 years, no comorbidi-
ties, a previous state of good health, lack of prior history of skin 
findings consistent with chilblains, lack of cold temperatures in 
the region, latency between mild systemic symptoms and the 
morphology of chilblains-like lesions and the development of 
similar finding in her pet cat.
In a recent article the Hubiche T et al. reported positive 
COVID-19 serology in only 30% of patients who presented with 
chilblains-like lesions suggesting that chilblains-like lesions are 
associated with mild or asymptomatic SARS-CoV-2 infection8. 
While our findings in combination may be coincidental, we 
hypothesize that there may be a delayed immune-mediated 
reaction to SARS-COV-2 in genetically predisposed patients 
who may test negative during a certain diagnostic window. 
Further studies are needed to determine the accurate diagnos-
tic window for COVID-19 diagnosis and possible cutaneous 
manifestations.
Consent
Written informed consent was obtained from the patient for 
the publication of this case report and any associated images.
Data availability
All data underlying the results are available as part of the article 
and no additional source data are required.
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My comments on RCm evaluation are still not answered by the authors. I was waiting for 
clarification of the following points: 
 
Dermal features (important for diagnosis) cannot be seen on confocal microscopy. Please, 
clarify this point and indicate the effective role of RCM in the evaluation of the case. 
 
○
Why the authors underline the absence of pagetoid cells in a non suspected melanocytic 
lesion? I personally do not think that this is the correct confocal description as this is not a 
melanocytic lesion... the report of absence of pagetoid cells is not necessary. 
 
○




I'd love to receive comments on the following queries I already indicated in my first review.”
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Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, 
Rzeszow, Poland 
The authors presented an interesting case of chilblains-like lesions in a 48-year-old woman. The 
case report is well-organized and written in a clear fashion. Furthermore, it includes dermoscopic 
and confocal findings of chilblains-like lesions. 
However, I have several comments and suggestions:




if available, please include lab findings (antinuclear antibodies? serology for 
Mycoplasma/Chlamydia infection? C-reactive protein?) 
 
○
I'm not a big supporter of the acronym introduced by the authors just to separate the name 
of the dermatological lesions from chronic lymphocytic leukemia (CLL).
○
The dermoscopic and confocal findings presented by the authors may be of some value for future 
diagnostic process of COVID-19-related lesions, but it should be taken into consideration that the 
infection was not confirmed in the presented patient and the authors only hypothesize that there 
may be a delayed immune-mediated reaction. Undoubtedly, further studies, comparing the 
dermoscopic and confocal features of COVID-19 toes and chilblains-like lesions resulting from 
other conditions are needed.
 
Is the background of the case’s history and progression described in sufficient detail?
Yes
Are enough details provided of any physical examination and diagnostic tests, treatment 
given and outcomes?
Yes
Is sufficient discussion included of the importance of the findings and their relevance to 
future understanding of disease processes, diagnosis or treatment?
Yes
Is the case presented with sufficient detail to be useful for other practitioners?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Dermoscopy, non-invasive skin imaging techniques
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard, however I have 
significant reservations, as outlined above.
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To Reviewer Dr. Magdalena Żychowska: All comments addressed, the abstract has been 
made longer including details regarding the presented case and findings; lab findings 
unavailable ; CCLL has been removed and it remains Chilblains-like lesions ; new citation 
added (number 8) and added in the discussion.  Thank you for your comments and 
suggestions  
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The authors demonstrated a case of chilblain-like lesions in a 48-year old woman. This case report 
is interesting, however, I have several comments, which can possibly be of relevance. Recently, "A 
COVID toe" has been described as a manifestation of COVID-19 infection. However, most reports 
are focused on single patients or demonstrate only a case series. Today, it is a matter of debate, 
whether indeed this is a specific cutaneous manifestation of COVID-19 infection or whether it may 
also result from other viral infections. In a recent study by Hubiche et al. (Hubiche T et al. Negative 
SARS-CoV-2 PCR in patients with chilblain-like lesions [published online ahead of print, 2020 Jun 
18]. Lancet Infect Dis. 2020;S1473-3099(20)30518-11) in only 30% of patients, COVID-19 infection 
(current or past) could be proofed. It is also important to exclude other causes of chilblains, mainly 
lupus erythematosus, which is not documented in current report.  
 
The authors also propose a new acronym for chilblains-like lesions with an additional word 
cutaneous (CCLL) to distinguish it from CLL - chronic lymphocytic leukemia. However, I disagree 
with such a proposal as adding a word "cutaneous" implicates that there are also extracutaneous 
manifestations of chilblains-like lesions, which is not the case in the current situation.    
 
Some minor comments: 
The authors should avoid to use the term "unique" in the abstract 
It is unclear, what the authors meant under the term "blister-like lesions" 
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Is the background of the case’s history and progression described in sufficient detail?
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future understanding of disease processes, diagnosis or treatment?
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Is the case presented with sufficient detail to be useful for other practitioners?
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This is a report of a case of chilblains-like lesions on a COVID-19+ patient. 
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Even if the case could be potentially interesting (several cases have been already reported in the 
literature) and it has been well presented, the use of confocal microscopy in this specific case does 
not add any new information with no distinctive features. 
 
Few points:
Dermal features (important for diagnosis) cannot be seen on confocal microscopy. 
 
○








In my view, this case report does not merit to be considered for indexing as it is presented.
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Yes
Are enough details provided of any physical examination and diagnostic tests, treatment 
given and outcomes?
Yes
Is sufficient discussion included of the importance of the findings and their relevance to 
future understanding of disease processes, diagnosis or treatment?
No
Is the case presented with sufficient detail to be useful for other practitioners?
No
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Rare skin diseases and non invasive techniques for skin analysis
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to state that I do not consider it to be of an acceptable scientific standard, for 
reasons outlined above.
 
Page 11 of 12
F1000Research 2020, 9:668 Last updated: 24 FEB 2021
The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias•
You can publish traditional articles, null/negative results, case reports, data notes and more•
The peer review process is transparent and collaborative•
Your article is indexed in PubMed after passing peer review•
Dedicated customer support at every stage•
For pre-submission enquiries, contact research@f1000.com
 
Page 12 of 12
F1000Research 2020, 9:668 Last updated: 24 FEB 2021
